 PLANO, Texas--BUSINESS WIRE--- RETA--Reata Pharmaceuticals, Inc. Nasdaq: RETA Reata, the Company, or we, a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs pre-market on November 8, 2021. Reatas management will host a conference call on November 8, 2021, at 8:30 a.m. ET. The conference call will be accessible by dialing 844 200-6205 toll-free domestic or 929 526-1599 i 